In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...

Chronic pain is a worldwide epidemic that disproportionately affects women. These surgeons have found innovative solutions - ...

Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues ...

These organizations can help you educate yourself, spread awareness, and connect with the MASH community to help you better manage your health.

Madrigal Pharmaceuticals Inc. (MDGL) is our top conservative biotech recommendation for 2025. The company is in the sweet spot and de-risked with the first FDA-approved drug for chronic liver ...

Background: Chronic liver diseases (CLD) continue to pose a significant global burden, potentially exacerbated by pro-inflammatory diets. This study explores the relationship between the Dietary ...

While simple steatosis may be clinically stable, nonalcoholic steatohepatitis (NASH) can be progressive. Inflammation is believed to be the driving force behind NASH and the progression to ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...